BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 6, 2016
View Archived Issues
Merus signs agreement for GlymaxX enhancement technology
Read More
MiNA Therapeutics initiates phase I trial of MTL-CEBPA in advanced liver cancer
Read More
Achaogen awarded funding for phase III EPIC study
Read More
FDA awards orphan drug designation to Escend's ES-3000 for CML
Read More
Kite Pharma enters research collaboration with Cell Design Labs
Read More
Arrien Pharmaceuticals begins phase I trials of ARN-6039
Read More
Anti-PD-1 MAb REGN-2810 well tolerated in first-in-human study in patients with solid tumors
Read More
Animal model studies give insight into mechanisms of disease
Read More
Afinitor receives approval in the E.U. for the treatment of advanced GI and lung NET
Read More
Foundation Medicine and AstraZeneca partner to develop companion diagnostic assay for Lynparza
Read More
GlaxoSmithKline patents SIRT1 activators
Read More
State University of New Jersey discloses compounds for metabolic diseases and cancer
Read More
Johns Hopkins University reports new drug conjugates
Read More
FORGE Life Science announces antiviral compounds
Read More
Ganymed presents promising preclinical data for its novel ADCs as treatments against cancer
Read More
Phase II/III trial of VLA-43 does not confirm previously seen positive vaccine effect
Read More
Array BioPharma, Pierre Fabre and Merck KGaA collaborate on BEACON CRC trial
Read More
Angiogenesis inhibitor X-82 combined with everolimus in patients with solid tumors
Read More
sDPP-IV levels associated with all-cause death in patients with PAD
Read More
The Global Health Innovative Technology reports new funding partnerships
Read More
Phase III study of dupilumab in moderate to severe atopic dermatitis meets key endpoints
Read More
Phase III trial of Actemra in giant cell arteritis meets key endpoints
Read More
Interim results show Frontier's phase III trial of albuvirtide for HIV meets primary objective
Read More
Vedanta raises new financing to advance microbiome therapeutics
Read More
IL-27p28 gene polymorphisms may be correlated with insulin resistance and artery disease
Read More